Fátima
Galán Sánchez
Publicaciones en las que colabora con Fátima Galán Sánchez (5)
2023
-
Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomonas aeruginosa infections
The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 5, pp. 1195-1200
2022
-
Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa
The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 10, pp. 2809-2815
2021
-
Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas aeruginosa infections
The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 1, pp. 91-100
2020
-
Molecular and biochemical insights into the in vivo evolution of AmpC-mediated resistance to ceftolozane/tazobactam during treatment of an MDR Pseudomonas aeruginosa infection
The Journal of antimicrobial chemotherapy, Vol. 75, Núm. 11, pp. 3209-3217
2019
-
Challenging antimicrobial susceptibility and evolution of resistance (oxa-681) during treatment of a long-term nosocomial infection caused by a pseudomonas aeruginosa ST175 Clone
Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 10